WO2006117624A3 - Kynurenic acid and salts thereof for the prevention and treatment of shock - Google Patents

Kynurenic acid and salts thereof for the prevention and treatment of shock Download PDF

Info

Publication number
WO2006117624A3
WO2006117624A3 PCT/IB2006/001059 IB2006001059W WO2006117624A3 WO 2006117624 A3 WO2006117624 A3 WO 2006117624A3 IB 2006001059 W IB2006001059 W IB 2006001059W WO 2006117624 A3 WO2006117624 A3 WO 2006117624A3
Authority
WO
WIPO (PCT)
Prior art keywords
shock
prevention
treatment
salts
kynurenic acid
Prior art date
Application number
PCT/IB2006/001059
Other languages
French (fr)
Other versions
WO2006117624A2 (en
Inventor
Flavio Moroni
Andrea Cozzi
Original Assignee
Univ Firenze
Flavio Moroni
Andrea Cozzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Firenze, Flavio Moroni, Andrea Cozzi filed Critical Univ Firenze
Publication of WO2006117624A2 publication Critical patent/WO2006117624A2/en
Publication of WO2006117624A3 publication Critical patent/WO2006117624A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The use in therapy of kynurenic acid and pharmaceutically acceptable salts there for preparing drugs effective in the prevention and treatment of shock, in particular septic shock, is described.
PCT/IB2006/001059 2005-04-29 2006-04-28 Kynurenic acid and salts thereof for the prevention and treatment of shock WO2006117624A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI2005A000083 2005-04-29
IT000083A ITFI20050083A1 (en) 2005-04-29 2005-04-29 USE OF KINURENIC ACID FOR THE PREVENTION AND TREATMENT OF SHOCK

Publications (2)

Publication Number Publication Date
WO2006117624A2 WO2006117624A2 (en) 2006-11-09
WO2006117624A3 true WO2006117624A3 (en) 2007-03-01

Family

ID=37307232

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/001059 WO2006117624A2 (en) 2005-04-29 2006-04-28 Kynurenic acid and salts thereof for the prevention and treatment of shock

Country Status (2)

Country Link
IT (1) ITFI20050083A1 (en)
WO (1) WO2006117624A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3055548B1 (en) * 2016-09-05 2018-09-28 Metabrain Research USE OF METABOLITES OF TRYPTOPHAN IN THE TREATMENT OF MUSCLE ATROPHY
PL234411B1 (en) 2017-01-20 2020-02-28 Milart Pawel Improved formula of preparations for oral and enteral nutrition of children

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007851A1 (en) * 1987-04-06 1988-10-20 Innovative Therapeutics Corporation Liposome entrapped n-methyl-d-aspartate receptor blockers
EP0432994A2 (en) * 1989-12-11 1991-06-19 John William Olney Excitatory amino acid antagonists as anti-emetic drugs
WO1993004688A1 (en) * 1991-09-09 1993-03-18 Warner-Lambert Company Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007851A1 (en) * 1987-04-06 1988-10-20 Innovative Therapeutics Corporation Liposome entrapped n-methyl-d-aspartate receptor blockers
EP0432994A2 (en) * 1989-12-11 1991-06-19 John William Olney Excitatory amino acid antagonists as anti-emetic drugs
WO1993004688A1 (en) * 1991-09-09 1993-03-18 Warner-Lambert Company Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHAW, R. C. & FEIGIN, R. D.: "Excretion of kynurenic acid and xanthurenic acid during infection", PEDIATRICS, vol. 47, no. 1, January 1971 (1971-01-01), pages 47 - 56, XP009074823 *

Also Published As

Publication number Publication date
ITFI20050083A1 (en) 2006-10-30
WO2006117624A2 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
WO2006074265A3 (en) Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
WO2007025005A3 (en) Sustained release formulations of nalbuphine
WO2007087068A3 (en) Inhibitors of tyrosine kinases and uses thereof
WO2007146426A3 (en) Nanoshells for drug delivery
WO2006060507A3 (en) Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
WO2005097119A3 (en) Pten inhibitors
AU2003210300A1 (en) The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
WO2004072031A3 (en) Phenylacetamides and their use as glucokinase modulators
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2006014973A3 (en) Pharmaceutical dosage forms including rasagiline
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2006116148A3 (en) (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse
EP1848418A4 (en) Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection
WO2006017822A3 (en) Quinazoline derivatives and their use in the treatment of thrombocythemia
WO2008029237A3 (en) Combination therapies for rheumatoid arthritis
ZA200808465B (en) Pharmaceutical formulations:salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
GB0222514D0 (en) Organic compounds
WO2007023072A3 (en) Use of ambroxol for the treatment of rhinovirus infections
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
EP1902715A3 (en) Use of paliperidone for the treatment of psychiatric patients with reduced hepatic function
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
WO2007083119A3 (en) Methods
WO2007144699A3 (en) Process for the preparation of alfuzosin

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06755843

Country of ref document: EP

Kind code of ref document: A2